Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in them.

In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses how patient education and remote monitoring can help with reducing the burden of trial participation.

The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of ...

If the future of oncology research is to be inclusive, efficient, and representative, community-based clinical trials must be ...

Clinical trials are essential for advancing medical treatments, yet participation from Black communities remains low due to misinformation.

What can Congress do to make clinical trials more accessible to patients? What are the biggest barriers to participation? And what does this all mean for the future of drug development?

In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change ...

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores ...

Federally Qualified Health Centers (FQHCs) often miss the mark when it comes to enrolling Black patients in clinical research trials.